CalciMedica CALC
NASDAQ CALC
$0.57 -0.01 (-1.52%)
As of: Aug 21, 2026 · 11:41 AM EDT

CalciMedica (CALC) Revenue (2024 - 2026)

CalciMedica's (CALC) quarterly Revenue came in at -$213000.0 in Q1 2026, up 13.06% YoY from -$188393.5 in Q1 2025, and down 22.41% on a QoQ basis from -$174000.0 in Q4 2025.

CalciMedica (CALC) Revenue (2024 - 2026) Analysis & Trends

CalciMedica (CALC) has 3 years of Revenue data on file, last reported at -$213000.0 in Q1 2026.

  • Quarterly Revenue rose 13.06% year-over-year to -$213000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.4 million (down 135.77% YoY) and the FY2025 annual result came in at -$91.9 million, down 5.14% from the prior year.
  • Revenue declined to -$213000.0 in Q1 2026, from -$174000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $214000.0 in Q4 2024 to a low of -$3.0 million in Q3 2025.
  • A 3-year average of -$599111.1 and a median of -$245000.0 in 2025 frame the typical range for Revenue.
  • The widest YoY moves for Revenue: up 71.82% in 2025, down 181.31% in 2025.
  • Tracing CALC's Revenue over 3 years: stood at $214000.0 in 2024, then slumped by 181.31% to -$174000.0 in 2025, then decreased by 22.41% to -$213000.0 in 2026.
  • The last three Revenue figures came in at -$213000.0 (Q1 2026), -$174000.0 (Q4 2025), and -$3.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 139.76 Bn 131.91 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 86.51 Bn 78.51 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 65.74 Bn 60.56 Bn 1.37 Bn 1.52 Bn
4 Moderna 59.39 Bn 54.26 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 42.24 Bn 37.15 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 31.78 Bn 28.47 Bn 992.69 Mn 1.29 Bn
7 BioNTech SE 28.65 Bn 10.26 Bn 668.28 Mn 1.06 Bn
8 Insmed 27.58 Bn 26.42 Bn 358.27 Mn 425.49 Mn
9 Royalty Pharma 27.22 Bn 26.39 Bn - 674.14 Mn
10 CalciMedica 9.82 Mn -8.79 Mn - -271,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -271,000.00
Mar 31, 2026 -213,000.00
Dec 31, 2025 -174,000.00
Sep 30, 2025 -2.96 Mn
Jun 30, 2025 -104,000.00
Mar 31, 2025 -245,000.00
Dec 31, 2024 214,000.00
Sep 30, 2024 -1.06 Mn
Jun 30, 2024 -369,000.00
Mar 31, 2024 -483,000.00